Algocare
Practice tests Home All programs

Parenteral Drug Administration

Introduction and Principles of Parenteral Drug Administration

Parenteral drug administration refers to the delivery of medications via routes other than the alimentary canal, bypassing the gastrointestinal tract entirely. Common routes include intravenous, intramuscular, subcutaneous, and intradermal injections. Nurses utilize parenteral routes when rapid drug action is required, when the patient cannot take oral medications due to nausea or unconsciousness, or when the drug would be destroyed by digestive secretions.

Selecting the correct route depends heavily on the pharmacokinetics of the drug and the desired onset of action. Intravenous injections provide the fastest systemic effect because the medication enters the bloodstream immediately. Conversely, subcutaneous and intradermal routes offer slower, more sustained absorption rates. The nurse must balance urgency, drug properties, and patient comfort when deciding how to administer a prescribed substance.

Safety, Aseptic Technique, and Infection Control

Administering medications via injection breaks the body's primary mechanical barrier, the skin, creating a direct pathway for pathogens. Strict aseptic technique is therefore non-negotiable. Nurses must protect sterile parts of equipment—including needles, syringes, and the hub of the IV catheter—from touching non-sterile surfaces.

Types of Parenteral Routes and Equipment Selection

Choosing the correct equipment ensures medication reaches the intended tissue layer safely. Syringes consist of a barrel, plunger, and tip, and vary in size from 1 mL to 60 mL. Needles are characterized by their length and gauge; the gauge number relates inversely to the needle diameter—a larger gauge number means a smaller needle bore.

RouteTypical Needle LengthTypical Needle GaugeTarget Tissue Layer
Intradermal1/4 to 1/2 inch25 to 27 gaugeDermis layer under epidermis
Subcutaneous3/8 to 5/8 inch25 to 30 gaugeLoose connective tissue below dermis
Intramuscular1 to 1.5 inches18 to 25 gaugeDeep skeletal muscle tissue

Selecting equipment also involves choosing filter needles when drawing medication from glass ampules to prevent glass shards from entering the final solution.

Intradermal and Subcutaneous Injections

Intradermal injections are administered into the dermis, just beneath the epidermis. Because blood supply in this layer is extremely limited, absorption is very slow. This route is primarily used for diagnostic tests, such as tuberculosis screening (Mantoux test) and allergy testing. The nurse inserts the needle with the bevel facing upward at a shallow angle of 5 to 15 degrees, watching for a small bleb or wheal to form on the skin.

Subcutaneous injections deliver medication into the loose connective tissue underlying the dermis. Common medications given subcutaneously include insulin and low-molecular-weight heparins. The nurse pinches the skin fold and inserts the needle at a 45-to-90-degree angle depending on patient adipose tissue mass and needle length. Site rotation is vital for patients receiving frequent subcutaneous injections, such as diabetics, to prevent lipodystrophy.

Intramuscular Injections and Landmark Identification

Intramuscular injections deliver medications deep into muscle tissue, which has a rich blood supply allowing for relatively rapid systemic absorption compared to subcutaneous routes. Successful delivery depends entirely on accurate anatomical landmarking to avoid damaging underlying nerves, bones, and blood vessels.

When giving irritating intramuscular medications, nurses utilize the Z-track technique. This involves displacing the skin laterally before insertion, sealing the medication within the muscle tissue and preventing leakage into subcutaneous tracks.

Intravenous Therapy and Access Management

Intravenous therapy involves cannulating a peripheral or central vein to infuse fluids, electrolytes, blood products, or medications directly into the systemic circulation. Peripheral lines are commonly placed in the hand or forearm veins. Nurses must monitor IV access sites continuously for signs of complications, including infiltration, phlebitis, and local infection.

Maintaining patency requires regular flushing with sterile normal saline according to facility protocol. If resistance is felt during a flush, the nurse must never force the fluid, as this can dislodge a blood clot or rupture the vessel wall. Strict aseptic technique during dressing changes and tubing replacements remains essential to prevent catheter-related bloodstream infections.

Patient Assessment and Pre-Administration Checks

Before administering any parenteral medication, the nurse performs a rigorous clinical assessment. This includes checking the patient's allergy history, current vital signs, and laboratory values that might affect drug clearance or safety. Renal and hepatic function test results are especially vital since many injected drugs are metabolized or excreted through these organs.

The foundation of safe administration rests upon executing the standard medication rights: right patient, right medication, right dose, right route, right time, right documentation, and right reason. The nurse compares the medication order against the patient's identification band and asks the patient to state their full name and date of birth whenever possible.

Complications, Prevention, and Nursing Management

Parenteral therapy carries inherent risks ranging from local tissue irritation to life-threatening systemic reactions. Nurses must recognize early warning signs and act swiftly to mitigate harm.

Documentation and Post-Administration Evaluation

Accurate documentation completes the medication administration cycle. The nurse records the exact drug name, dose, route, time, and injection site immediately after administration. Delayed documentation increases the risk of accidental duplicate dosing by other healthcare team members.

Post-administration evaluation is equally critical. The nurse returns to assess the patient for therapeutic effectiveness and monitor for delayed adverse reactions. For instance, pain medications require a follow-up assessment within 30 to 60 minutes to evaluate pain relief, while intravenous antibiotics require monitoring for signs of hypersensitivity or infusion site irritation.

Test yourself on this topic →
Privacy Policy Terms & Disclaimer